These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 15949342)

  • 21. Thymidine phosphorylase activity in renal cell carcinoma: relationship between histological parameters and chemosensitivity to fluorouracil-related drugs.
    Hirano Y; Takayama T; Kageyama S; Ushiyama T; Suzuki K; Fujita K
    Urol Res; 2002 May; 30(2):112-5. PubMed ID: 12086015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Down regulation of c-Myc and induction of an angiogenesis inhibitor, thrombospondin-1, by 5-FU in human colon cancer KM12C cells.
    Zhao HY; Ooyama A; Yamamoto M; Ikeda R; Haraguchi M; Tabata S; Furukawa T; Che XF; Iwashita K; Oka T; Fukushima M; Nakagawa M; Ono M; Kuwano M; Akiyama S
    Cancer Lett; 2008 Oct; 270(1):156-63. PubMed ID: 18583030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of human peptide transporter 1 (PEPT1) in gastric cancer cells by anticancer drugs.
    Inoue M; Terada T; Okuda M; Inui K
    Cancer Lett; 2005 Dec; 230(1):72-80. PubMed ID: 16253763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of 5-fluorouracil host-toxicity and chemotherapeutic efficacy against human colon tumors by 5-(Phenylthio)acyclouridine, a uridine phosphorylase inhibitor.
    Al Safarjalani ON; Rais R; Shi J; Schinazi RF; Naguib FN; el Kouni MH
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):692-8. PubMed ID: 16528530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytokines induce thymidine phosphorylase expression in tumor cells and make them more susceptible to 5'-deoxy-5-fluorouridine.
    Eda H; Fujimoto K; Watanabe S; Ura M; Hino A; Tanaka Y; Wada K; Ishitsuka H
    Cancer Chemother Pharmacol; 1993; 32(5):333-8. PubMed ID: 8339382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The activity of thymidine phosphorylase obtained from human uterine leiomyomas and studied in the presence of pyrimidine derivatives.
    Miszczak-Zaborska E; Woźniak K
    Z Naturforsch C J Biosci; 1997; 52(9-10):670-5. PubMed ID: 9373996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cross-resistance of 5-fluorouracil-resistant colon carcinoma in vitro.
    Ratzenboeck IE; Bartl B; Forstner B; Kalipciyan M; Steger GG; Mader RM
    Int J Clin Pharmacol Ther; 2011 Jan; 49(1):81-2. PubMed ID: 21176738
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of 5-Fluorouracil on Thymidine Phosphorylase Activity in Model Experiment.
    Stashkevich MA; Khomutov EV; Dumanskii YV; Matvienko AG; Zinkovich II
    Bull Exp Biol Med; 2016 Mar; 160(5):646-8. PubMed ID: 27021101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of Nrf2 activation in resistance to 5-fluorouracil in human colon cancer HT-29 cells.
    Akhdar H; Loyer P; Rauch C; Corlu A; Guillouzo A; Morel F
    Eur J Cancer; 2009 Aug; 45(12):2219-27. PubMed ID: 19524433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene expression profiling of colon cancer reveals a broad molecular repertoire in 5-fluorouracil resistance.
    Schmidt WM; Kalipciyan M; Dornstauder E; Rizovski B; Sedivy R; Steger GG; Müller MW; Mader RM
    Int J Clin Pharmacol Ther; 2003 Dec; 41(12):624-5. PubMed ID: 14692722
    [No Abstract]   [Full Text] [Related]  

  • 31. Modulation of 5-fluorouracil by interferon: a review of potential cellular targets.
    Horowitz R; Schwartz EL; Wadler S
    Med Oncol; 1995 Mar; 12(1):3-8. PubMed ID: 8542244
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of combined administration of DPD-inhibitory oral fluoropyrimidine, S-1, plus paclitaxel on gene expressions of fluoropyrimidine metabolism-related enzymes in human gastric xenografts.
    Sakurai Y; Yoshida I; Kamoshida S; Inaba K; Isogaki J; Komori Y; Uyama I; Tsutsumi Y
    Ann Surg Oncol; 2008 Aug; 15(8):2301-9. PubMed ID: 18506536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene expression of 5-fluorouracil metabolic enzymes in primary gastric cancer: correlation with drug sensitivity against 5-fluorouracil.
    Kodera Y; Ito S; Fujiwara M; Mochizuki Y; Nakayama G; Ohashi N; Koike M; Yamamura Y; Nakao A
    Cancer Lett; 2007 Jul; 252(2):307-13. PubMed ID: 17303323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Choline kinase down-regulation increases the effect of 5-fluorouracil in breast cancer cells.
    Mori N; Glunde K; Takagi T; Raman V; Bhujwalla ZM
    Cancer Res; 2007 Dec; 67(23):11284-90. PubMed ID: 18056454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular basis for the induction of an angiogenesis inhibitor, thrombospondin-1, by 5-fluorouracil.
    Zhao HY; Ooyama A; Yamamoto M; Ikeda R; Haraguchi M; Tabata S; Furukawa T; Che XF; Zhang S; Oka T; Fukushima M; Nakagawa M; Ono M; Kuwano M; Akiyama S
    Cancer Res; 2008 Sep; 68(17):7035-41. PubMed ID: 18757417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 5-Fluorouracil-related gene expression in primary sites and hepatic metastases of colorectal carcinomas.
    Sameshima S; Tomozawa S; Kojima M; Koketsu S; Motegi K; Horikoshi H; Okada T; Kon Y; Sawada T
    Anticancer Res; 2008; 28(3A):1477-81. PubMed ID: 18630501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Silencing hexokinase II gene sensitizes human colon cancer cells to 5-fluorouracil.
    Peng Q; Zhou J; Zhou Q; Pan F; Zhong D; Liang H
    Hepatogastroenterology; 2009; 56(90):355-60. PubMed ID: 19579598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combining siRNAs at two different sites in the EGFR to suppress its expression, induce apoptosis, and enhance 5-fluorouracil sensitivity of colon cancer cells.
    Wu X; Deng Y; Wang G; Tao K
    J Surg Res; 2007 Mar; 138(1):56-63. PubMed ID: 17169374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of p53 expression in response to 5-fluorouracil in human cancer RKO cells.
    Ju J; Schmitz JC; Song B; Kudo K; Chu E
    Clin Cancer Res; 2007 Jul; 13(14):4245-51. PubMed ID: 17634554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A mechanism for the potentiation of the cytotoxic effects of antimetabolites drugs (FT-207, 5FU) by hyperthermia.
    Iwagaki H; Fuchimoto S; Shiiki S; Miyake M; Orita K
    Res Commun Chem Pathol Pharmacol; 1988 Nov; 62(2):353-60. PubMed ID: 3150792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.